105 related articles for article (PubMed ID: 3298542)
1. Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria.
Tashiro M; Klenk HD; Rott R
J Gen Virol; 1987 Jul; 68 ( Pt 7)():2039-41. PubMed ID: 3298542
[TBL] [Abstract][Full Text] [Related]
2. Role of Staphylococcus protease in the development of influenza pneumonia.
Tashiro M; Ciborowski P; Klenk HD; Pulverer G; Rott R
Nature; 1987 Feb 5-11; 325(6104):536-7. PubMed ID: 3543690
[TBL] [Abstract][Full Text] [Related]
3. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.
Tashiro M; Ciborowski P; Reinacher M; Pulverer G; Klenk HD; Rott R
Virology; 1987 Apr; 157(2):421-30. PubMed ID: 3029981
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the growth of human coronavirus 229E by leupeptin.
Appleyard G; Tisdale M
J Gen Virol; 1985 Feb; 66 ( Pt 2)():363-6. PubMed ID: 3968542
[TBL] [Abstract][Full Text] [Related]
5. The effect of vitamin E on secondary bacterial infection after influenza infection in young and old mice.
Gay R; Han SN; Marko M; Belisle S; Bronson R; Meydani SN
Ann N Y Acad Sci; 2004 Dec; 1031():418-21. PubMed ID: 15753185
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.
Sgarbanti R; Nencioni L; Amatore D; Coluccio P; Fraternale A; Sale P; Mammola CL; Carpino G; Gaudio E; Magnani M; Ciriolo MR; Garaci E; Palamara AT
Antioxid Redox Signal; 2011 Aug; 15(3):593-606. PubMed ID: 21366409
[TBL] [Abstract][Full Text] [Related]
7. Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease.
Reddinger RM; Luke-Marshall NR; Hakansson AP; Campagnari AA
mBio; 2016 Aug; 7(4):. PubMed ID: 27507829
[TBL] [Abstract][Full Text] [Related]
8. Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production.
Subramaniam R; Barnes PF; Fletcher K; Boggaram V; Hillberry Z; Neuenschwander P; Shams H
J Infect Dis; 2014 Jun; 209(11):1827-36. PubMed ID: 24367039
[TBL] [Abstract][Full Text] [Related]
9. [Cleavage of influenza virus hemagglutinin as affected by serum plasmin in cell culture and in vivo].
Zhirnov OP; Ovcharenko AV; Bukrinskaia AG
Vopr Virusol; 1981; (6):677-87. PubMed ID: 6461136
[TBL] [Abstract][Full Text] [Related]
10. Sequential virus infections, bacterial superinfections, and fibrogenesis.
Jakab GJ
Am Rev Respir Dis; 1990 Aug; 142(2):374-9. PubMed ID: 2166456
[TBL] [Abstract][Full Text] [Related]
11. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry.
Boycott R; Klenk HD; Ohuchi M
Virology; 1994 Sep; 203(2):313-9. PubMed ID: 8053155
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of influenza virus A/WSN replication by a trypsin inhibitor, 6-amidino-2-naphthyl p-guanidinobenzoate.
Someya A; Tanaka N; Okuyama A
Biochem Biophys Res Commun; 1990 May; 169(1):148-52. PubMed ID: 2350338
[TBL] [Abstract][Full Text] [Related]
13. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
Okumura Y; Takahashi E; Yano M; Ohuchi M; Daidoji T; Nakaya T; Böttcher E; Garten W; Klenk HD; Kido H
J Virol; 2010 May; 84(10):5089-96. PubMed ID: 20219906
[TBL] [Abstract][Full Text] [Related]
14. Suppression of influenza virus replication in infected mice by protease inhibitors.
Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
J Gen Virol; 1984 Jan; 65 ( Pt 1)():191-6. PubMed ID: 6198446
[TBL] [Abstract][Full Text] [Related]
15. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
[TBL] [Abstract][Full Text] [Related]
16. [Role of sulfatide on influenza A virus replication].
Suzuki T; Takahashi T; Suzuki Y
Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1676-82. PubMed ID: 21089387
[No Abstract] [Full Text] [Related]
17. Interactions between bacteria and influenza A virus in the development of influenza pneumonia.
Scheiblauer H; Reinacher M; Tashiro M; Rott R
J Infect Dis; 1992 Oct; 166(4):783-91. PubMed ID: 1527412
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones.
Garten W; Stieneke A; Shaw E; Wikstrom P; Klenk HD
Virology; 1989 Sep; 172(1):25-31. PubMed ID: 2773317
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of influenza virus formation by a peptide that corresponds to sequences in the cytoplasmic domain of the hemagglutinin.
Collier NC; Knox K; Schlesinger MJ
Virology; 1991 Aug; 183(2):769-72. PubMed ID: 1853575
[TBL] [Abstract][Full Text] [Related]
20. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis.
Garten W; Vey M; Ohuchi R; Ohuchi M; Klenk HD
Behring Inst Mitt; 1991 Jul; (89):12-22. PubMed ID: 1930091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
